HEREDITARY AND ACQUIRED P53 GENE-MUTATIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA

被引:101
作者
FELIX, CA
NAU, MM
TAKAHASHI, T
MITSUDOMI, T
CHIBA, I
POPLACK, DG
REAMAN, GH
COLE, DE
LETTERIO, JJ
WHANGPENG, J
KNUTSEN, T
MINNA, JD
机构
[1] NCI,PEDIAT BRANCH,BETHESDA,MD 20892
[2] NCI,USN,MED ONCOL BRANCH,BETHESDA,MD 20892
[3] NCI,MED BRANCH,BETHESDA,MD 20892
[4] CHILDRENS HOSP,NATL MED CTR,DIV HEMATOL ONCOL,WASHINGTON,DC 20010
[5] GEORGE WASHINGTON UNIV,SCH MED,DEPT PEDIAT,WASHINGTON,DC 20010
[6] UNIV TEXAS,HLTH SCI CTR,SW MED SCH,SIMMONS CANC CTR,DALLAS,TX 75235
关键词
B-CELL PRECURSOR; GERMLINE; LI-FRAUMENI SYNDROME; T-CELL; TUMOR SUPPRESSOR GENE;
D O I
10.1172/JCI115630
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The p53 gene was examined in primary lymphoblasts of 25 pediatric patients with acute lymphoblastic leukemia by the RNase protection assay and by single strand conformation polymorphism analysis in 23 of 25 cases. p53 mutations were found to occur, but at a low frequency (4 of 25). While all four mutations were identified by single strand conformation polymorphism, the comparative sensitivity of RNase protection was 50% (2 of 4). Heterozygosity was retained at mutated codons in 3 of 4 cases. One pedigree was consistent with the Li-Fraumeni syndrome, and bone marrow from both diagnosis and remission indicated a germline G to T transversion at codon 272 (valine to leucine). Although members of another family were affected with leukemia, a 2-bp deletion in exon 6 was nonhereditary. The other two nonhereditary p53 mutations included a T to G transversion at codon 270 (phenylalanine to cysteine) and a G to C transversion at codon 248 (arginine to proline). These data support the role of both hereditary and acquired p53 mutations in the pathogenesis and/or progression of some cases of childhood acute lymphoblastic leukemia.
引用
收藏
页码:640 / 647
页数:8
相关论文
共 52 条
[11]   GENETIC MECHANISMS OF TUMOR SUPPRESSION BY THE HUMAN P53 GENE [J].
CHEN, PL ;
CHEN, YM ;
BOOKSTEIN, R ;
LEE, WH .
SCIENCE, 1990, 250 (4987) :1576-1580
[12]   FREQUENT MUTATIONS IN THE P53 TUMOR SUPPRESSOR GENE IN HUMAN LEUKEMIA T-CELL LINES [J].
CHENG, J ;
HAAS, M .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) :5502-5509
[13]  
CHIBA I, 1990, ONCOGENE, V5, P1603
[14]  
DAMICO D, 1991, IN PRESS ONCOGENE
[15]   WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767
[16]  
ELIYAHU D, 1988, ONCOGENE, V3, P313
[17]   T-CELL RECEPTOR ALPHA-GENES, BETA-GENES, AND GAMMA-GENES IN T-CELL AND PRE-B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
FELIX, CA ;
WRIGHT, JJ ;
POPLACK, DG ;
REAMAN, GH ;
COLE, D ;
GOLDMAN, P ;
KORSMEYER, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (02) :545-556
[18]   CHARACTERIZATION OF IMMUNOGLOBULIN AND T-CELL RECEPTOR GENE PATTERNS IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD [J].
FELIX, CA ;
POPLACK, DG ;
REAMAN, GH ;
STEINBERG, SM ;
COLE, DE ;
TAYLOR, BJ ;
BEGLEY, CG ;
KIRSCH, IR .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :431-442
[19]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[20]   MUTATION IS REQUIRED TO ACTIVATE THE P53 GENE FOR COOPERATION WITH THE RAS ONCOGENE AND TRANSFORMATION [J].
HINDS, P ;
FINLAY, C ;
LEVINE, AJ .
JOURNAL OF VIROLOGY, 1989, 63 (02) :739-746